Biohaven tumbles as migraine drug efficacy fails to impress investors
Biohaven Pharmaceutical Holding said its migraine treatment met the main goals in two late-stage studies… Read More
8 years ago
Biohaven Pharmaceutical Holding said its migraine treatment met the main goals in two late-stage studies… Read More
SINGAPORE: Oil prices tumbled on Wednesday as Donald Trump stunned the world by winning the… Read More
LONDON: Alarm bells rang across world markets on Monday as a near 9 percent dive… Read More